0001209191-23-038606.txt : 20230621 0001209191-23-038606.hdr.sgml : 20230620 20230620184159 ACCESSION NUMBER: 0001209191-23-038606 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230616 FILED AS OF DATE: 20230620 DATE AS OF CHANGE: 20230620 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cline Darren S CENTRAL INDEX KEY: 0001633639 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40353 FILM NUMBER: 231026908 MAIL ADDRESS: STREET 1: 35 CAMBRIDGE PARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IMPEL PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001445499 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 263058238 STATE OF INCORPORATION: DE FISCAL YEAR END: 0426 BUSINESS ADDRESS: STREET 1: 201 ELLIOTT AVE. W STREET 2: SUITE 260 CITY: SEATTLE STATE: WA ZIP: 98119 BUSINESS PHONE: 206-568-1466 MAIL ADDRESS: STREET 1: 201 ELLIOTT AVE. W STREET 2: SUITE 260 CITY: SEATTLE STATE: WA ZIP: 98119 FORMER COMPANY: FORMER CONFORMED NAME: IMPEL NEUROPHARMA INC DATE OF NAME CHANGE: 20080917 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-06-16 0 0001445499 IMPEL PHARMACEUTICALS INC IMPL 0001633639 Cline Darren S C/O IMPEL PHARMACEUTICALS INC. 201 ELLIOTT AVE W, STE 260 SEATTLE WA 98119 1 0 0 0 0 Stock Option (right to buy) 1.34 2023-06-16 4 A 0 13222 0.00 A 2033-06-15 Common Stock 13222 13222 D The option is 100% vested on June 16, 2024. /s/ John Hoekman, Ph.D. as attorney-in-fact 2023-06-20